Company Tagline
Your Truth Detector in Patient Prognostics, Drug Development and Use, Improving Success-Rates from Targets to Patients.
Industry Category
Business Keywords
Company Description
BioPhenyx is a leading biotechnology research company committed to advancing patient prognostics and drug development. Through innovative approaches and cutting-edge technologies like CRISPR-Select, BioPhenyx delivers reliable insights into drug targets and patient responses, improving success rates from initial targets to patient outcomes. BioPhenyx is dedicated to providing exceptional data on the role of molecular targets in disease etiology and their responsiveness to drug candidates, which is critical for the improved development of therapeutics. By reducing attrition rates in development programs and clinical trials, BioPhenyx contributes to more efficient and effective healthcare solutions.
Located at Nordre Fasanvej 215, Frederiksberg, Capital Region of Denmark 2000, DK, BioPhenyx offers precise, fast, and quantitative analysis of candidate drug targets and drug responses in cells. With the CRISPR-Select technology, BioPhenyx performs analysis in weeks without the need for cell line generation and clonal selection, addressing critical questions in a timely and efficient manner. BioPhenyx continues to drive advancements in the biotechnology sector with a focus on improving patient care and treatment efficacy.
BioPhenyx remains at the forefront of biotechnology, enhancing its capabilities and expanding its reach to serve a growing global clientele. The company’s commitment to innovation and excellence positions it as a key player in the future of patient prognostics and drug development. We invite the manager of BioPhenyx to create a customized and exclusive company showcase and product listing on our platform to further enhance their market presence.
BioPhenyx er en førende virksomhed inden for bioteknologisk forskning, der er engageret i at fremme patientprognoser og lægemiddeludvikling. Gennem innovative tilgange og avancerede teknologier som CRISPR-Select leverer BioPhenyx pålidelig indsigt i lægemål og patientsvar, hvilket forbedrer succesrater fra indledende mål til patientresultater. BioPhenyx er dedikeret til at levere exceptionelle data om molekylære måls rolle i sygdomsætiologi og deres reaktionsevne over for lægemiddelkandidater, hvilket er afgørende for forbedret udvikling af terapeutika. Ved at reducere frafald i udviklingsprogrammer og kliniske forsøg bidrager BioPhenyx til mere effektive og virkningsfulde sundhedsløsninger.
Beliggende på Nordre Fasanvej 215, Frederiksberg, Capital Region of Denmark 2000, DK, tilbyder BioPhenyx præcis, hurtig og kvantitativ analyse af kandidatlægemål og lægemiddelresponser i celler. Med CRISPR-Select-teknologien udfører BioPhenyx analyse på få uger uden behov for cellelinjegenerering og klonal selektion, hvilket adresserer kritiske spørgsmål på en rettidig og effektiv måde. BioPhenyx fortsætter med at drive fremskridt inden for bioteknologisektoren med fokus på at forbedre patientpleje og behandlingseffektivitet.
BioPhenyx forbliver på forkant med bioteknologi og forbedrer sine evner og udvider sin rækkevidde for at betjene en voksende global kundekreds. Virksomhedens engagement i innovation og ekspertise positionerer den som en nøglespiller i fremtiden for patientprognoser og lægemiddeludvikling. Vi inviterer lederen af BioPhenyx til at oprette et tilpasset og eksklusivt firmashowcase og produktfortegnelse på vores platform for yderligere at forbedre deres markedstilstedeværelse.
Key Personnel / Employees
Similar Companies
Other organizations in the same industry
FeniQX S.r.l.
Biotechnology-ResearchForniamo stampanti 3D, scanner e software CAD/CAM al settore dentale, con assistenza completa nel pa...
Stem Cell Association
Biotechnology-ResearchThis association has been founded by engineering and medicine students from SUT and TUMS
Ncardia
Biotechnology-ResearchNcardia believes that human stem cell (iPSCs) technologies will bring better therapies to patients f...
Alternative Company Names
This company is also known as